Skip to main content

Nonprofit · EIN 91-1457505

OXALOSIS AND HYPEROXALURIA FOUNDATION

Tax-exempt · NEW PALTZ, NY 12561

Financials

$1.3M$706K2023$1.6M$1.3M2024
Revenue Expenses · by fiscal year end
Financials of OXALOSIS AND HYPEROXALURIA FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$1,552,797$1,296,330$256,467$6,858,963$429,901$6,429,062
December 31, 2023990$1,285,664$706,363$579,301$6,411,517$204,565$6,206,952
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$749,795
Membership dues
$95,000
Program service revenue
$299,450
Investment income
$503,552
Net gain from sales of assets
$320,249
Other revenue
$0

Expenses

Grants and similar amounts paid
$632,009
Compensation of officers, directors and key employees
$231,000
Other salaries and wages
$88,956
Salaries, compensation and benefits (total)
$367,047
Professional fundraising fees
$0
Accounting fees
$39,864
Travel
$51,959
Depreciation
$758
Program services (functional)
$1,166,724
Management and general (functional)
$115,960
Fundraising (functional)
$13,646

Balance sheet and other

Total assets, start of year
$6,411,517
Total assets, end of year
$6,858,963
Total liabilities, end of year
$429,901
Net assets, end of year
$6,429,062
Land, buildings and equipment
$758
Publicly traded securities
$6,242,841
Net assets without donor restrictions
$6,218,837
Net assets with donor restrictions
$210,225
Gross receipts
$2,686,500
Employees
3
Volunteers
10
Year formed
2001
State of legal domicile
WA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
Kim HollanderExecutive Director
Key employee
40$231,000$22,394
William TidmorePresident
Trustee or director, Officer
5$0$0
Tim BerraVice-President
Trustee or director, Officer
5$0$0
Brett RosenChair/Treasurer
Trustee or director, Officer
5$0$0
Art McGillDirector
Trustee or director
5$0$0
Brendan McGovernDirector
Trustee or director
5$0$0
Debbie WattenbergDirector
Trustee or director
5$0$0
990 for the year ended December 31, 2023: 7 people
NameTitleHours / weekCompensation
Kim HollanderExecutive Director
Key employee
40$220,630
Brendan McGovernPresident/Director
Trustee or director, Officer
5$0
Tim BerraVice-President
Trustee or director, Officer
5$0
Brett RosenTreasurer
Trustee or director, Officer
5$0
Art McGillDirector
Trustee or director
5$0
William TidmoreDirector/President
Trustee or director, Officer
5$0
Debbie WattenbergDirector
Trustee or director
5$0

Address and contacts

Address (IRS master file)
579 ALBANY POST RD, NEW PALTZ, NY 12561-3629
In care of
% KIM HOLLANDER
Principal officer (990 for 2024)
Kim Hollander, 579 Albany Post Road, New Paltz, NY 12561
Signed the 990
Kim Hollander, Executive Director
Phone
(212) 777-0470
Return prepared by
Aprio Advisory Group LLC

Mission

Our vision: a world without hyperoxaluria - dedicated to improving the daily lives of people with hyperoxaluria. We have a single, urgent goal: eradicating all forms of hyperoxaluria disease forever.

990 for the year ended December 31, 2024

Program accomplishments

  • Hyperoxaluria Research Grants and Programs:- The OHF has invested millions of dollars to energize and support scientific research with the ultimate goal of finding a cure.- OHF is a recognized leader and innovator in the Primary and Enteric Hyperoxaluria field and serves as a trusted resource for patients, families, healthcare professionals, and researchers.- OHF provides research grants, patient and professional educational conferences, newsletters, mailings, and Medical Advisory Board meetings to advance knowledge and collaboration.-OHF conducts educational workshops worldwide, offering valuable information to:Patients and caregivers,Physicians who provide care,Research scientists seeking to develop more effective treatments.
    Expenses $632,009 · grants $632,009
  • Patient and professional educational conferences, newsletters, mailings, medical advisory board conferences.
    Expenses $534,715 · revenue $299,450

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
91-1457505
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (509(a)(2))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1994
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$6,858,963
Income (IRS master file)
$2,686,500

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$1,552,797$1,296,330$6,858,963XML
990December 2023$1,285,664$706,363$6,411,517XML
990December 2022$936,432$640,998$5,524,708IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 91-1457505).

Questions about OXALOSIS AND HYPEROXALURIA FOUNDATION

What is the EIN of OXALOSIS AND HYPEROXALURIA FOUNDATION?
The employer identification number (EIN) of OXALOSIS AND HYPEROXALURIA FOUNDATION is 91-1457505.
Is OXALOSIS AND HYPEROXALURIA FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1994.
Are donations to OXALOSIS AND HYPEROXALURIA FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does OXALOSIS AND HYPEROXALURIA FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of OXALOSIS AND HYPEROXALURIA FOUNDATION due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did OXALOSIS AND HYPEROXALURIA FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of OXALOSIS AND HYPEROXALURIA FOUNDATION?
The 990 for the year ended December 31, 2024 names Kim Hollander.
Who are the officers and directors of OXALOSIS AND HYPEROXALURIA FOUNDATION?
The 990 for the year ended December 31, 2024 lists 7 people; 1 received compensation from the organization, the highest $231,000 (Kim Hollander, Executive Director).
How much revenue does OXALOSIS AND HYPEROXALURIA FOUNDATION have?
On its 990 for the year ended December 31, 2024 it reported revenue of $1,552,797, expenses of $1,296,330 and total assets of $6,858,963 at year end.

Other nonprofits in NEW PALTZ

All nonprofits in NEW PALTZ · New York · Voluntary health associations and medical disciplines